Cervical cancer is the fourth leading cause of cancer-related deaths among women globally, with over 660,000 cases and 340,000 deaths —94% of which occur in LMICs due to limited access to screening and care. Dr.CerviCARE® AI addresses these gaps by offering a groundbreaking AI-assisted cervical cancer screening system that works offline, unlike previous systems that required internet connectivity. Specifically designed for low-resource settings, this device provides consistency regardless of location or operator skill. Providing expert-level analysis within five seconds, Dr.CerviCARE® AI demonstrated promising outcomes in recent field study conducted in Can Tho, Vietnam. Among more than 1,500 women screened, approximately 80 tested positive and 12 were diagnosed with cervical cancer, enabling earlier detection. Providing practical support for cervical cancer even in low-resource settings, Dr.CerviCARE® AI, aligning with the WHO 90-70-90 strategy, helps expand equitable access to cervical cancer prevention and early detection worldwide.